연구성과로 돌아가기
2020 연구성과별 연구자 정보 (62 / 2428)
※ 현재 Web of Science 저자 정보만 집계되어 있습니다.
※ 컨트롤 + 클릭으로 열별 다중 정렬 가능합니다.
Excel 다운로드
| Document Title | Author Full Name | Author Short Name | Index | Corresponding | Address | ResearcherID | ResearcherID Author Name | ORCID | ORCID Author Name | Related Email |
|---|---|---|---|---|---|---|---|---|---|---|
| A Pharmacokinetic Drug Interaction Between Fimasartan and Linagliptin in Healthy Volunteers | Cho, Seungil | Cho, S | 4 | Kyungpook Natl Univ Hosp, Dept Clin Pharmacol, Daegu, South Korea | wintersj@knu.ac.kr;yry@knu.ac.kr; | |||||
| A Pharmacokinetic Drug Interaction Between Fimasartan and Linagliptin in Healthy Volunteers | Shim, Wang-Seob | Shim, WS | 5 | Kyungpook Natl Univ, Sch Med, Dept Mol Med, Daegu, South Korea | wintersj@knu.ac.kr;yry@knu.ac.kr; | |||||
| A Pharmacokinetic Drug Interaction Between Fimasartan and Linagliptin in Healthy Volunteers | Shim, Wang-Seob | Shim, WS | 5 | Kyungpook Natl Univ Hosp, Dept Clin Pharmacol, Daegu, South Korea | wintersj@knu.ac.kr;yry@knu.ac.kr; | |||||
| A Pharmacokinetic Drug Interaction Between Fimasartan and Linagliptin in Healthy Volunteers | Lee, Kyung-Tae | Lee, KT | 6 | Kyung Hee Univ, Kyung Hee Drug Anal Ctr, Seoul, South Korea | wintersj@knu.ac.kr;yry@knu.ac.kr; | |||||
| A Pharmacokinetic Drug Interaction Between Fimasartan and Linagliptin in Healthy Volunteers | Yang, Dong Heon | Yang, DH | 7 | Kyungpook Natl Univ, Sch Med, Dept Internal Med, Div Cardiol, Daegu 41944, South Korea | wintersj@knu.ac.kr;yry@knu.ac.kr; | |||||
| A Pharmacokinetic Drug Interaction Between Fimasartan and Linagliptin in Healthy Volunteers | Seong, Sook Jin | Seong, SJ | 8 | 교신저자 | Kyungpook Natl Univ, Sch Med, Dept Mol Med, Daegu, South Korea | wintersj@knu.ac.kr;yry@knu.ac.kr; | ||||
| A Pharmacokinetic Drug Interaction Between Fimasartan and Linagliptin in Healthy Volunteers | Seong, Sook Jin | Seong, SJ | 8 | 교신저자 | Kyungpook Natl Univ Hosp, Dept Clin Pharmacol, Daegu, South Korea | wintersj@knu.ac.kr;yry@knu.ac.kr; | ||||
| A Pharmacokinetic Drug Interaction Between Fimasartan and Linagliptin in Healthy Volunteers | Yoon, Young-Ran | Yoon, YR | 9 | 교신저자 | Kyungpook Natl Univ, Sch Med, Dept Mol Med, Daegu, South Korea | GLT-0172-2022 | Yoon, Young-Ran | wintersj@knu.ac.kr;yry@knu.ac.kr; | ||
| A Pharmacokinetic Drug Interaction Between Fimasartan and Linagliptin in Healthy Volunteers | Yoon, Young-Ran | Yoon, YR | 9 | 교신저자 | Kyungpook Natl Univ Hosp, Dept Clin Pharmacol, Daegu, South Korea | GLT-0172-2022 | Yoon, Young-Ran | wintersj@knu.ac.kr;yry@knu.ac.kr; | ||
| A phase 3 study comparing switching from tenofovir disoproxil fumarate (TDF) to tenofovir alafenamide (TAF) with continued TDF treatment in virologically-suppressed patients with chronic hepatitis B (CHB): final week 96 efficacy and safety results | Lampertico, Pietro | Lampertico, P | 1 | Univ Milan, Fdn IRCCS Ca Granda Osped Maggiore Policlin, Milan, Italy | pietro.lampertico@unimi.it; | |||||
| A phase 3 study comparing switching from tenofovir disoproxil fumarate (TDF) to tenofovir alafenamide (TAF) with continued TDF treatment in virologically-suppressed patients with chronic hepatitis B (CHB): final week 96 efficacy and safety results | Buti, Maria | Buti, M | 2 | Hosp Gen Univ Valle Hebron & Ciberehd, Barcelona, Spain | A-5327-2019 | Buti, MARIA | pietro.lampertico@unimi.it; | |||
| A phase 3 study comparing switching from tenofovir disoproxil fumarate (TDF) to tenofovir alafenamide (TAF) with continued TDF treatment in virologically-suppressed patients with chronic hepatitis B (CHB): final week 96 efficacy and safety results | Ramji, Alnoor | Ramji, A | 3 | Univ British Columbia, Div Gastroenterol, Vancouver, BC, Canada | pietro.lampertico@unimi.it; | |||||
| A phase 3 study comparing switching from tenofovir disoproxil fumarate (TDF) to tenofovir alafenamide (TAF) with continued TDF treatment in virologically-suppressed patients with chronic hepatitis B (CHB): final week 96 efficacy and safety results | Fung, Scott | Fung, S | 4 | Toronto Gen Hosp, Univ Hlth Network, Toronto Ctr Liver Dis, Toronto, ON, Canada | pietro.lampertico@unimi.it; | |||||
| A phase 3 study comparing switching from tenofovir disoproxil fumarate (TDF) to tenofovir alafenamide (TAF) with continued TDF treatment in virologically-suppressed patients with chronic hepatitis B (CHB): final week 96 efficacy and safety results | Ahn, Sang Hoon | Ahn, SH | 5 | Yonsei Univ, Inst Gastroenterol, Dept Internal Med, Coll Med, Seoul, South Korea | AAV-2600-2020 | SANG-HOON, AHN | pietro.lampertico@unimi.it; | |||
| A phase 3 study comparing switching from tenofovir disoproxil fumarate (TDF) to tenofovir alafenamide (TAF) with continued TDF treatment in virologically-suppressed patients with chronic hepatitis B (CHB): final week 96 efficacy and safety results | Chuang, Wan-Long | Chuang, WL | 6 | Kaohsiung Med Univ Hosp, Hepatobiliary Div, Dept Internal Med, Kaohsiung, Taiwan | C-9536-2009 | Chuang, Wan-Long | 0000-0002-2376-421X | Chuang, Wan-Long | pietro.lampertico@unimi.it; |
페이지 이동: